Nothing Special   »   [go: up one dir, main page]

HUP9902415A2 - Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására - Google Patents

Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására

Info

Publication number
HUP9902415A2
HUP9902415A2 HU9902415A HUP9902415A HUP9902415A2 HU P9902415 A2 HUP9902415 A2 HU P9902415A2 HU 9902415 A HU9902415 A HU 9902415A HU P9902415 A HUP9902415 A HU P9902415A HU P9902415 A2 HUP9902415 A2 HU P9902415A2
Authority
HU
Hungary
Prior art keywords
administration
producing
same
release forms
solid instant
Prior art date
Application number
HU9902415A
Other languages
English (en)
Inventor
Rolf-Dieter Gabel
Alexander Wirl
Heinrich Woog
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of HUP9902415A2 publication Critical patent/HUP9902415A2/hu
Publication of HUP9902415A3 publication Critical patent/HUP9902415A3/hu
Publication of HU224953B1 publication Critical patent/HU224953B1/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

A találmány őlyan szilárd, azőnnal felszabadűló beadási főrmákra (IR-beadási főrmák) vőnatkőzik, amelyek őlyan terápiás hatóanyagőkat vagyhatóanyag-kőncentrátűmőkat tartalmaznak, különösen nűkleőzidőklipidkőnjűgátűmait főglalják magűkban, amelyek gélképzőtűlajdőnságőkat műtatnak vizes közegekben. A találmány kiterjed ezekelőállítására alkalmas eljárásra is. ŕ
HU9902415A 1996-01-26 1997-01-24 Solid instant-release forms of administration and process for producing the same HU224953B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19602757A DE19602757A1 (de) 1996-01-26 1996-01-26 Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung
PCT/EP1997/000329 WO1997026867A2 (de) 1996-01-26 1997-01-24 Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
HUP9902415A2 true HUP9902415A2 (hu) 1999-11-29
HUP9902415A3 HUP9902415A3 (en) 1999-12-28
HU224953B1 HU224953B1 (en) 2006-04-28

Family

ID=7783738

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9902415A HU224953B1 (en) 1996-01-26 1997-01-24 Solid instant-release forms of administration and process for producing the same

Country Status (21)

Country Link
US (1) US6521262B2 (hu)
EP (1) EP0877605B1 (hu)
JP (1) JP2000506512A (hu)
KR (1) KR19990082039A (hu)
CN (1) CN1214629A (hu)
AT (1) ATE226065T1 (hu)
AU (1) AU717456B2 (hu)
BR (1) BR9707083A (hu)
CA (1) CA2243964A1 (hu)
CZ (1) CZ298897B6 (hu)
DE (2) DE19602757A1 (hu)
ES (1) ES2184987T3 (hu)
HU (1) HU224953B1 (hu)
IL (1) IL125474A (hu)
MX (1) MX9805939A (hu)
NO (1) NO323625B1 (hu)
NZ (1) NZ331051A (hu)
PL (1) PL328157A1 (hu)
RU (1) RU2175547C2 (hu)
WO (1) WO1997026867A2 (hu)
ZA (1) ZA97596B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2241342C (en) * 1998-06-15 2000-02-08 Bernard Charles Sherman Pharmaceutical tablets comprising an nsaid and a prostaglandin
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
RU2338753C2 (ru) * 2002-03-26 2008-11-20 Новартис Вэксинес Энд Дайэгностикс С.Р.Л. Модифицированные сахариды, имеющие улучшенную стабильность в воде
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
DE60301351T2 (de) * 2003-07-25 2006-01-19 Ferring B.V. Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung
GB0323103D0 (en) * 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
AU2005321239B2 (en) 2004-12-30 2009-02-12 Medivir Ab Compounds useful in the treatment of HIV
RU2311916C2 (ru) * 2005-09-27 2007-12-10 Галина Михайловна Сафонова Средство, обладающее антианемическим, иммуномодулирующим, адаптогенным действием (варианты)
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
US4283394A (en) * 1979-08-06 1981-08-11 Research Corporation Cytotoxic nucleoside-corticosteroid phosphodiesters
US4622392A (en) * 1984-06-21 1986-11-11 Health Research Inc. (Roswell Park Division) Thiophospholipid conjugates of antitumor agents
US4605551A (en) * 1984-11-30 1986-08-12 William H. Rorer, Inc. Dry oil coated antacid process
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US4999189A (en) 1988-11-14 1991-03-12 Schering Corporation Sustained release oral suspensions
SE9003902D0 (sv) * 1990-12-07 1990-12-07 Astra Ab Solid dosage forms of a drug
DE4026265A1 (de) 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel

Also Published As

Publication number Publication date
KR19990082039A (ko) 1999-11-15
WO1997026867A2 (de) 1997-07-31
ES2184987T3 (es) 2003-04-16
IL125474A (en) 2001-12-23
WO1997026867A3 (de) 1997-09-25
MX9805939A (es) 1998-11-30
DE19602757A1 (de) 1997-07-31
HUP9902415A3 (en) 1999-12-28
AU717456B2 (en) 2000-03-23
CA2243964A1 (en) 1997-07-31
NO323625B1 (no) 2007-06-18
HU224953B1 (en) 2006-04-28
JP2000506512A (ja) 2000-05-30
CN1214629A (zh) 1999-04-21
NZ331051A (en) 2000-01-28
PL328157A1 (en) 1999-01-18
CZ232098A3 (cs) 1998-10-14
NO983437L (no) 1998-09-28
US20020122817A1 (en) 2002-09-05
CZ298897B6 (cs) 2008-03-05
AU1594897A (en) 1997-08-20
ZA97596B (en) 1998-07-24
EP0877605B1 (de) 2002-10-16
BR9707083A (pt) 1999-03-23
EP0877605A2 (de) 1998-11-18
DE59708495D1 (de) 2002-11-21
IL125474A0 (en) 1999-03-12
US6521262B2 (en) 2003-02-18
RU2175547C2 (ru) 2001-11-10
NO983437D0 (no) 1998-07-24
ATE226065T1 (de) 2002-11-15

Similar Documents

Publication Publication Date Title
EP0693281A3 (en) Pharmaceutical preparations containing fluoxetine
AU6279996A (en) Methods of delivering materials into the skin, and compositions used therein
CA2219502A1 (en) Methods and formulations for modulating the human sexual response
GR1002451B (el) Αντιφλεγμονωδεις συνθεσεις που εχουν ως βαση ενεργα συστατικα ορισμενων βοτανων χρησιμοποιουμενες για σκοπους ιατρικους και κτηνιατρικους, και μεθοδοι παρασκευης φαρμακων και σκευασματων για τους παραπανω σκοπους.
BG103552A (en) Therapeutical forms
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
MX9602973A (es) Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida.
IL109534A0 (en) Pour-on formulations containing polymeric material, glycols and glycerides and a process for their preparation
BR9509975A (pt) Formulação farmacêutica
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
BG105275A (en) Tan-1057 derivatives
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
CA2340734A1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
GEP20022751B (en) Aqueous Pharmaceutical Composition Comprising an Active Ingredient Which Is Highly Insoluble in Water
IL118218A (en) Pharmaceutical compositions containing sarcodictyins
HUP9902032A2 (hu) Peszticid készítmény
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
EP0373771A3 (en) New pharmaceutical uses for cystatins
CA2091134A1 (en) Therapeutic agent for threatened abortion
IE870577L (en) Topical amide preparation
CA2429793A1 (en) Interferon therapeutic effect enhancer
FR2437832A1 (fr) Medicament a base de p-tolyl diiodomethylsulfone utile notamment pour le traitement des infections cutanees provoquees par les levures et les champignons

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees